I love the last statement the best.. "After all he has raised enough capital to get us where we are and built solid enough connections for people to trust him enough to sell him these assets."
The capital he has raised is exactly why we are where we are at. Trust? Companies were trying to get these assets off their hands as quick as possible, just like I would imagine we are trying to do now.
Most all of you know that I have been here since beginning of 2012 and had all the confidence in the world in the company's vision and strategy. When Gerald put out his blogs, I had no reason to doubt him and made my investing decision based on his updates, always hoping that he was a man of integrity. Well, as of recent, I question that integrity. I question what he meant when he spoke of "shareholder value". I question what he meant when he spoke of "institutional investors" wanting to get in. Where did they go? I question his rush to up list. I question all of his "NDA's". Did they really ever exist or were those total lies? I question all of the "Great interest in KOL's". Besides the interest in ESS from the burn community, what about everything else? Tax credit? What happened to that? Where are all of the grants that we hired a paid employee to find for us? Other than Dr. Lowe (and his contract expiring explanation) , what is up with talent leaving AMBS? I could just continue on and on if I had the motivation to go back in history and comments from Gerald and point out that his statements either lacked evidence completely and would just be considered hearsay or would fall under the classification of delusion.
There are those that will point out the things "he has accomplished", but as a shareholder, I could care less that he has all these assets that it seems BP's and these supposed "institutional investors" are not interested in, and that in return we are sitting with 90-95 % losses over the last three years. Average down? What if you didn't have the money to average down and made your initial investment decision based on the info coming from management. Has a single milestone been met? We have jumped around, trying to find that magical asset that will generate non dilutive funding, but here we are about to be reversed split into oblivion. My shares are worth nothing at this point and will be worth less once that happens.
I understand those that have thrown in the towel and feel as if Gerald does not "deserve" to continue to screw (misstate the facts and continually over promise) over any other/future investors. His lack of communication and outright lies (oops I mean "overstatements" in his previous blogs reeks of indifference to shareholders and boarder on deceptive communication.
At this point, it would be ridiculous to sell my shares. What would be the point? However, as of today, based on history, I could care less and actually hope for his demise. I can only judge a man by his actions. His actions have spoken WAY louder than his words. By not communicating what has been going on with the company, getting into bed with financiers that did not have AMBS's interest at heart, thereby risking our investment and destroying the share price, as he has done , is not excusable. I would have been able to forgive had he been transparent all along concerning his mistakes and how he planned to correct them, but leaving us all just wondering (take a look at all the posts the last few months with everyone "speculating" about what "must be going on". I spend the last nights reviewing posts from others on the board and we are all clueless. Clueless is not a good thing in the market. Go back and read the chairman's blogs. If there was ever a pumper, it was Gerald.
As I stated on the private board (which got me kicked off) I would exit this stock at break even just based on my standards of integrity, which I feel this company has sorely lacked. I am almost positive I will never see break even.
Sorry, but just had to vent. Been sitting here reading everyone's posts about what they think will happen and resigning to the fact that they have no choice but to vote in the additional shares as their only chance of ever getting their money back. What kind of position is that? Allow a irresponsible and uncommunicative CEO, cart blanche to save your own asses? At some point in time, unless he comes out and apologizes to shareholders for his mismanagement and lousy "financial engineering" of our hard earned money, I say, end the madness. I made a bad investment decision, am down over 90% and don't really care about the money as much as I care about not allowing an imbecile to continue on diluting us into oblivion after mentioning at one time that a "reverse split might not be necessary" and that he would only RS ONLY "into strength". It pains me to have to write this and I suspect that there are many others on this board that would echo my sentiment, but are afraid to share for being accused of being a basher or a "short" with an agenda. That sucks to!!! Here's to hoping we all become rich.....lol Most likely not with this investment.....at least from my perspective today.
International Infusion
Gerald and John Commissiong are constantly getting accused of being liars. This is far from the case. I would argue that Gerald Commissiong is Amarantus. In just a few years lets see what Gerald has managed to pull off. He has spent the last few years positioning MANF for clinicals while adding not one but two robust divisions. The therapeutics division has been slowly building a pipeline of potential blockbuster therapeutics.
The acquisition of Eltropozine was essential in the diversification of the company and the phase 2b trial has already dosed their first patient in only one of the indicators that the potential treatment will be used for. You can anticipate that good data from this study wont only get the attention of big pharma but they will be ready to bring their check books with them. Any partnership will most likely open up the company to going after the other indications that eltropizine has the ability to treat. Good data will also bring in more attention that could result in institutions bringing their checkbooks too!
ESS is just brilliant. Yes there has been trouble around this asset but not because the asset doesn't work. Rather the trials were mismanaged. What does this create? Opportunity! And Gerald ceased it- He recently finalized the acquisition and managed to do this for pennies on the dollar. With trials slated to start in either Q3 or Q4 look to see a steady update on how the effectiveness of ESS is performing. If it is close to what its potential is then we will see in my opinion national attention.
MANF is still brewing. This protein has a lot of hype and excitement around it. Gaining an International Interest, it will be costly to get this developed to the point of commercialization but with a little work it can be done. The key is to not give it away too early. Management has already done a great job on building its value by gaining multiple orphans indications and aligning partnerships with key universities to continue building its value by gaining multiple orphans indications and aligning partnerships with key universities to continue building the program. This potential blockbuster could create Amarantus into one of the pharmaceutical juggernauts. If a trial is successfully completed then watch out for large pharmaceuticals to do anything they can to get their hands on it!
Sounds like a lot?!? Well, Gerald was just warming up. He recently has created Amarantus DX. They boost that this will be the most robust neurological diagnostic line of assets ever assembled inside of one company. Many ways to play this and it will be interesting to see if he spins this out or keeps it in house. But you can beat that the company is working on it. With acceptance of data into major journals, the word about MS Precise is getting out there. The result is that Amarantus was able to attract a top advisory board with high levels of industry experience to the company. From Dr. Goix to Dr. Wand to Mr. Guillen their expertise and connections reaches through the heart of the diagnostic community. Raising over $70mm in equity capital, Dr. Giox also developed revenues of over $60mm annually. Why would they join? One would speculate that they see the potential of the assets.
On the doorstep of commercialization, MS Precise is ready to run through. Yes, it will take a few years to maximize revenue but the process is started and there are plans to have this hit commercialization soon. The recent journal news shows that the medical community is taking note and will give doctors the confidence they need to one day use the diagnostic. Lympro has been constantly criticized on the message boards and shareholders seem very confused on this asset. The recent data released has shown consistency and if this consistency is further supported by PET imaging then it could be special. The first customer has been brought in and if a heavy hitter comes in and uses Lympro then we can expect others will follow.
The Georgetown Assays are also in the mix and you can bet that the newly assembled teams will be eager to further develop these assays and complete the acquisition.
This is a lot and I would argue that Gerald is the best one for the job. After all he has raised enough capital to get us where we are and built solid enough connections for people to trust him enough to sell him these assets. These companies all have back end incentives for Gerald to be successful and wouldn't sell them to just anyone.
